Abstract:The retail e-commerce yields lucrative revenue in many industries. In this work, we provide a strategic perspective by investigating how consumer valuation, product quality, and manufacturers’ competition influence the choice of selling agreement using stylized models. The utility and valuations of consumers are involved in analyzing strategic decisions under different selling agreement that is not trivial to analyze. We first show that agency selling agreement induces a higher retail price, but this can benefit the entire channel; under this agreement, the agency fee and consumer valuation present a nonmonotonic (approximately U-shaped) relation. Even though double marginalization exists, reselling agreement induces the manufacturer to make low-quality product compared to the agency selling agreement, but such a low-quality product is only profitable for the manufacturer. Second, when introducing manufacturers' competition, agency selling agreement can induce a wider quality difference: higher high-quality and lower low-quality. Agency selling agreement also hurts the manufacturer and the entire channel, but this is a preferred format for the low-quality manufacturer. Both the high-quality manufacturer and the entire channel and are profitable to choose the reselling agreement; offering a high-quality product can hurt the manufacturer remains robust. Third, the first-mover manufacturer can get a lower profit than the follower retailer. Moreover, when comparing scenarios with alternative sequences of making decisions, first-mover can lead to disadvantage, in that both supply chain parties prefer to act later rather than earlier. Our work also explains the rationale about why e-commerce firms in China now pay more attention to low-end consumers.

Effects of price regulation and bargaining on pharmaceutical supply chain considering the pharmacy's sales effort

Effects of Price Cap Regulation on the Pharmaceutical Supply Chain

Evaluating the Effects of Quality Regulations on the Pharmaceutical Supply Chain

Pricing and Ordering Strategies in China's Pharmaceutical Supply Chains With Mandatory Replenishment Mechanism

Effects of Pharmaceutical Price Regulation: China'S Evidence Between 1997 and 2008

Research on Closed Loop Supply Chain with Reference Price Effect

Evaluating the Effects of China's Price Regulation on Pharmaceutical Market During 1997～2008

Effects of Pricing Schemes and Platform Types on Platform-Based Logistics Services.

The International Regulation Methods of Pharmaceutical Pricing and Their Impacts:A Systematic Review

A new pricing mechanism for pharmaceutical supply chains: a game theory analytical approach for healthcare service

Pricing Models of E-Books when Competing with P-Books

Interactive bundle pricing strategy for online pharmacies

The Equilibrium between Regulated Prices and R&D Expenditure on New Drugs

Supplier Encroachment under Nonlinear Pricing with Imperfect Substitutes: Bargaining Power Versus Revenue-Sharing

Pricing and Replenishment Policies in a Supply Chain with Competing Retailers under Different Retail Behaviors

Marketing and pricing strategies of online pharmacies

A study of legal framework of national drug price negotiations in China

Competition Between Brand-Name and Generics--analysis on Pricing of Brand-Name Pharmaceutical.

Reselling or Agency Selling? Consumer Valuation, Quality Design, and Manufacturers' Competition

Pricing strategies for competitive firms with indirect network effects

Modeling And Solving A Pricing Problem Considering Substitutable Products In A Dual Supply Chain With Internet And Traditional Distribution Channels